World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

James Judson Biography and Net Worth

Director of Omnicell

James T. Judson has served as a Director of Omnicell since April 2006. Mr. Judson joined Omnicell in February 2005 as Vice President, Finance and was appointed Executive Vice President, Finance, and Chief Financial Officer in April of that year. He then served as Omnicell’s Vice President, Corporate Development from March through July of 2006. Mr. Judson has over 30 years of financial management experience, including 20 years with Sun Microsystems, Inc., a computer systems and software company. He served as Vice President of Finance and Planning for the Worldwide Operations Group of Sun Microsystems from 1998 until his retirement from the company in 2002. Mr. Judson’s career included executive leadership roles in strategic planning, systems and business process re-engineering, acquisition integration, pricing, tax strategies, and external reporting. Mr. Judson received a BS in Industrial Management from Purdue University and an MBA in Finance from Indiana University.

What is James T. Judson's net worth?: The estimated net worth of James T. Judson is at least $632,671.60 as of August 23rd, 2021. Mr. Judson owns 23,320 shares of Omnicell stock worth more than $632,672 as of April 25th. This net worth estimate does not reflect any other assets that Mr. Judson may own. Learn More about James T. Judson's net worth.
How do I contact James T. Judson?: The corporate mailing address for Mr. Judson and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on James T. Judson's contact information.
Has James T. Judson been buying or selling shares of Omnicell?: James T. Judson has not been actively trading shares of Omnicell during the last quarter. Most recently, James T. Judson sold 4,984 shares of the business's stock in a transaction on Monday, August 23rd. The shares were sold at an average price of $153.00, for a transaction totalling $762,552.00. Following the completion of the sale, the director now directly owns 23,320 shares of the company's stock, valued at $3,567,960. Learn More on James T. Judson's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, Omnicell insiders bought shares 1 times. They purchased a total of 4,000 shares worth more than $295,040.00. During the last year, insiders at the sold shares 1 times. They sold a total of 7,951 shares worth more than $581,536.14. The most recent insider tranaction occured on June, 9th when EVP Christine Marie Mellon sold 7,951 shares worth more than $581,536.14. Insiders at Omnicell own 2.6% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 6/9/2023.

James T. Judson Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/23/2021	Sell	4,984	$153.00	$762,552.00	23,320
11/1/2018	Sell	2,443	$70.67	$172,646.81	24,952
10/1/2018	Sell	5,000	$71.18	$355,900.00	29,952
9/4/2018	Sell	5,000	$68.90	$344,500.00	34,952
8/1/2018	Sell	5,000	$58.76	$293,800.00	39,952
5/26/2017	Sell	12,148	$41.50	$504,142.00	19,130
8/9/2016	Sell	6,250	$37.98	$237,375.00	15,300
6/2/2015	Sell	8,032	$36.83	$295,818.56
2/2/2015	Sell	5,000	$31.61	$158,050.00
1/2/2015	Sell	5,000	$32.36	$161,800.00
12/1/2014	Sell	5,000	$31.94	$159,700.00
11/3/2014	Sell	5,000	$32.27	$161,350.00
10/1/2014	Sell	5,000	$27.02	$135,100.00
9/2/2014	Sell	5,000	$28.18	$140,900.00
8/26/2014	Sell	9,913	$27.91	$276,671.83
7/1/2014	Sell	5,000	$29.28	$146,400.00
10/1/2013	Sell	5,000	$23.66	$118,300.00
7/1/2013	Sell	5,000	$20.46	$102,300.00

James T. Judson Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $27.13

$26.74

$27.44

50 Day Range

MA: $27.70

$26.15

$29.24

2 Week Range

Now: $27.13

$25.69

$77.14

Volume

500,170 shs

Average Volume

540,423 shs

Market Capitalization

$1.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Click here to find out what to do.